Antibe Therapeutics's total assets for Q3 2024 were C$56.36M, a decrease of -6.38% from the previous quarter. ATBPF total liabilities were C$30.43M for the fiscal quarter, a -0.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.